Cano Health (CANO) Tops Q1 EPS by 4c; FY22 Guidance

Cano Health (NYSE: CANO) reported Q1 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $704.3 million versus the consensus estimate of $666.03 million.

GUIDANCE:

Cano Health sees FY2022 revenue of $2.8-2.9 billion.

For earnings history and earnings-related data on Cano Health (CANO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c